Drug Type Recombinant polypeptide |
Synonyms- |
Target |
Action inhibitors |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors) |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | - | 07 Apr 2023 | |
Cardiovascular Diseases | Discovery | - | 07 Apr 2023 | |
Immune System Diseases | Discovery | - | 07 Apr 2023 | |
Immune System Diseases | Discovery | - | 07 Apr 2023 | |
Nutritional and Metabolic Diseases | Discovery | - | 07 Apr 2023 | |
Nutritional and Metabolic Diseases | Discovery | - | 07 Apr 2023 |